Steroid Elimination-Who, When, How?

Transplantation Proceedings

Volumn 40, Issue 10 SUPPL., 2008, Pages

  Matas, A J ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; AZATHIOPRINE; CALCINEURIN INHIBITOR; CYCLOSPORIN A; CYTOKINE RECEPTOR ANTAGONIST; INTERLEUKIN 2 INHIBITOR; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG;

ACUTE GRAFT REJECTION; AREA UNDER THE CURVE; ARTICLE; CATARACT; CLINICAL TRIAL; DRUG WITHDRAWAL; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LOW DRUG DOSE; MAINTENANCE THERAPY; MONOTHERAPY; PRIORITY JOURNAL; TREATMENT WITHDRAWAL;

ADRENAL CORTEX HORMONES; ANTILYMPHOCYTE SERUM; CLINICAL TRIALS AS TOPIC; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; PREDNISONE;

EID: 57649093611     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2008.10.007     Document Type: Article

References (77)

1. Citterio F. Steroid side effects and their impact on transplantation outcome. Transplantation 72 (2001) S75
2. Vanrenterghem Y.F., Claes K., Montagnino G., et al. Risk factors for cardiovascular events after successful renal transplantation. Transplantation 85 (2008) 209
3. Veenstra D.L., Best J.H., Hornberger J., et al. Incidence and long-term cost of steroid-related side effects after renal transplantation. Am J Kidney Dis 33 (1999) 829
4. Schweizer R.T., Rovelli M., Palmeri D., et al. Noncompliance in organ transplant recipients. Transplantation 49 (1990) 374
5. Nevins T.E., Kruse L., Skeans M.A., et al. The natural history of azathioprine compliance after renal transplantation. Kidney Int 60 (2001) 1565
6. Prasad G.V., Nash M.M., McFarlane P.A., et al. Renal transplant recipient attitudes toward steroid use and steroid withdrawal. Clin Transplant 17 (2003) 135
7. Hricik D.E., O'Toole M.A., Schulak J.A., et al. Steroid-free immunosuppression in cyclosporine-treated renal transplant recipients: a meta-analysis. J Am Soc Nephrol 4 (1993) 1300
8. Kasiske B.L., Chakkera H.A., Louis T.A., et al. A meta-analysis of immunosuppression withdrawal trials in renal transplantation. J Am Soc Nephrol 11 (2000) 1910
9. Pascual J., Quereda C., Zamora J., et al. Steroid withdrawal in renal transplant patients on triple therapy with a calcineurin inhibitor and mycophenolate mofetil: a meta-analysis of randomized, controlled trials. Transplantation 78 (2004) 1548
10. Sinclair N.R. Low-dose steroid therapy in cyclosporine-treated renal transplant recipients with well-functioning grafts. CMAJ 147 (1992) 645
11. Basadonna G.P., Matas A.J., Gillingham K.J., et al. Early versus late acute renal allograft rejection: impact on chronic rejection. Transplantation 55 (1993) 993
12. Almond P.S., Matas A., Gillingham K., et al. Risk factors for chronic rejection in renal allograft recipients. Transplantation 55 (1993) 752
13. Opelz G., Döhler B., Laux G., and Collaborative Transplant Study. Long-term prospective study of steroid withdrawal in kidney and heart transplant recipients. Am J Transplant 5 (2005) 720
14. Buchler M., Caillard S., Barbier S., et al. Sirolimus versus cyclosporine in kidney recipients receiving thymoglobulin, mycophenolate mofetil and a 6-month course of steroids. Am J Transplant 7 (2007) 2522
15. Mahalati K., and Kahan B.D. A pilot study of steroid withdrawal from kidney transplant recipients on sirolimus-cyclosporine a combination therapy. Transplant Proc 33 (2001) 3232
16. Citterio F., Sparacino V., Altieri P., et al. Addition of sirolimus to cyclosporine in long-term kidney transplant recipients to withdraw steroid. Transplant Proc 37 (2005) 827
17. Hricik D.E., Knauss T.C., Bodziak K.A., et al. Withdrawal of steroid therapy in AA kidney transplant recipients receiving sirolimus and tacrolimus. Transplantation 76 (2003) 938
18. Hricik D.E., Augustine J.J., Knauss T.C., et al. Long-term graft outcomes after steroid withdrawal in AA kidney transplant recipients receiving sirolimus and tacrolimus. Transplantation 83 (2007) 277
19. Birkeland S.A. Steroid-free immunosuppression after kidney transplantation with antithymocyte globulin induction and cyclosporine and mycophenolate mofetil maintenance therapy. Transplantation 73 (2002) 1527
20. Birkeland S.A. Steroid-free immunosuppression in renal transplantation: a long-term follow-up of 100 consecutive patients. Transplantation 71 (2001) 1089
21. Matas A.J. Minimization of steroids in kidney transplantation. Transpl Int (2008) Jul 24. [Epub ahead of print]
22. Vincenti F., Monaco A., Grinyo J., et al. Multicenter randomized prospective trial of steroid withdrawal in renal transplant recipients receiving basiliximab, cyclosporine microemulsion and mycophenolate mofetil. Am J Transplant 3 (2003) 306
23. ter Meulin C.G., van Riemsdijk I., Hené R.J., et al. Steroid-withdrawal at 3 days after renal transplantation with anti-IL-2 receptor α therapy: a prospective, randomized, multicenter study. Am J Transplant 4 (2004) 803
24. Rostaing L., Cantarovich D., Mourad G., et al. Corticosteroid-free immunosuppression with tacrolimus, mycophenolate mofetil, and daclizumab induction in renal transplantation. Transplantation 79 (2005) 807
25. Vitko S., Klinger M., and Salmela K. Two corticosteroid-free regimens-tacrolimus monotherapy after basiliximab administration and tacrolimus/mycophenolate mofetil-in comparison with a standard triple regimen in renal transplantation: results of the Atlas Study. Transplantation 80 (2005) 1734
26. Woodle E.S., and TRIMS Study Group. A randomized, prospective, multicenter comparative study evaluating a thymoglobulin-based early corticosteroid cessation regimen in renal transplantation (TRIMS). Transplantation 82 Suppl 3 (2006) 294
27. Vincenti F., Schena F.P., Paraskevas S., et al. A randomized, multicenter study of steroid avoidance, early steroid withdrawal or standard steroid therapy in kidney transplant recipients. Am J Transplant 8 (2008) 307
28. Laftavi M.R., Stephan R., Stefanick B., et al. Randomized prospective trial of early steroid withdrawal compared with low-dose steroids in renal transplant recipients using serial protocol biopsies to assess efficacy and safety. Surgery 137 (2005) 364
29. Woodle E.S., and Astellas Steroid Withdrawal Study Group. A randomized double blind, placebo-controlled trial of early corticosteroid cessation versus chronic corticosteroids: three year results. Transplantation 82 Suppl3 (2006) 177
30. Montagnino G., Sandrini S., Iorio B., et al. A randomized exploratory trial of steroid avoidance in renal transplant patients treated with everolimus and low-dose cyclosporine. Nephrol Dial Transplant 23 (2008) 707
31. Kumar M.S., Heifets M., Moritz M.J., et al. Safety and efficacy of steroid withdrawal two days after kidney transplantation: analysis of results at three years. Transplantation 81 (2006) 832
32. Kumar M.S.A., Heifets M., Fyfe B., et al. Comparison of steroid avoidance in tacrolimus/mycophenolate mofetil and tacrolimus/sirolimus combination in kidney transplantation monitored by surveillance biopsy. Transplantation 80 (2005) 807
33. Boots J.M., Christiaans M.H.L., Van Duijnhoven E.M., et al. Early steroid withdrawal in renal transplantation with tacrolimus dual therapy: a pilot study. Transplantation 74 (2002) 1703
34. Cole E., Landsberg D., David R., et al. A pilot study of steroid-free immunosuppression in the prevention of acute rejection in renal allograft recipients. Transplantation 72 (2001) 845
35. Rajab A., Pelletier R.P., Henry M.L., et al. Excellent clinical outcomes in primary kidney transplant recipients treated with steroid-free maintenance immunosuppression. Clin Transplant 20 (2006) 537
36. Woodle E.S., Vincenti F., Lorber M.I., et al. A multicenter pilot study of early (4-day) steroid cessation in renal transplant recipients under simulect, tacrolimus and sirolimus. Am J Transplant 5 (2005) 157
37. Jaber J.J., Feustel P.J., Elbahloul O., et al. Early steroid withdrawal therapy in renal transplant recipients: a steroid-free sirolimus and CellCept-based calcineurin inhibitor-minimization protocol. Clin Transplant 21 (2007) 101
38. Matas A.J., Ramcharan T., Paraskevas S., et al. Rapid discontinuation of steroids in living donor kidney transplantation: a pilot study. Am J Transplant 1 (2001) 278
39. Humar A., Kandaswamy R., Payne W., et al. Long-term follow-up of > 1,000 kidney transplant recipients on prednisone-free maintenance immunosuppression. Am J Transplant 8 Suppl2 (2008) 300
40. Matas A.J., Kandaswamy R., Humar A., et al. Long-term immunosuppression, without maintenance prednisone, after kidney transplantation. Ann Surg 240 (2004) 510
41. Gallon L.G., Winoto J., Leventhal J.R., et al. Effect of prednisone versus no prednisone as part of maintenance immunosuppression on long-term renal transplant function. Clin J Am Soc Nephrol 1 (2006) 1029
42. van den Ham E.C., Kooman J.P., Christiaans M.H., et al. Weight changes after renal transplantation: a comparison between patients on 5-mg maintenance steroid therapy and those on steroid-free immunosuppressive therapy. Transplant Int 16 (2003) 300
43. Mataunami C., Hilton A.F., Dyer J.A., et al. Ocular complications in renal transplant patients. Aust N Z J Ophthalmol 22 (1994) 53
44. Julian B.A., Laskow D.A., Dubovsky J., et al. Rapid loss of vertebral mineral density after renal transplantation. N Engl J Med 325 (1991) 544
45. Wolpaw T., Deal C.L., Fleming-Brooks S., et al. Factors influencing vertebral bone density after renal transplantation. Transplantation 58 (1994) 1186
46. Lo Cascio V., Bonucci E., Imbimbo B., et al. Bone loss after glucocorticoid therapy. Calcif Tissue Int 36 (1984) 435
47. Laan R.F., van Riel P.L., van de Putte L.B., et al. Low-dose prednisone induces rapid reversible axial bone loss in patients with rheumatoid arthritis: a randomized, controlled study. Ann Intern Med 119 (1993) 963
48. van Staa T.P., Leufkens H.G., Abenhaim L., et al. Oral corticosteroids and fracture risk: relationship to daily and cumulative doses. Rheumatology (Oxford) 39 (2000) 1383
49. Gluck O.S., Murphy W.A., Hahn T.J., et al. Bone loss in adults receiving alternate day glucocorticoid therapy: a comparison with daily therapy. Arthritis Rheum 24 (1981) 892
50. Ruegsegger P., Medici T.C., and Anliker M. Corticosteroid-induced bone loss: a longitudinal study of alternate day therapy in patients with bronchial asthma using quantitative computed tomography. Eur J Clin Pharmacol 25 (1983) 615
51. Birkeland S.A., Larsen K.E., and Rohr N. Pediatric renal transplantation without steroids. Pediatr Nephrol 12 (1998) 87
52. Sarwal M.M., Yorgin P.D., Alexander S., et al. Promising early outcomes with a novel, complete steroid avoidance immunosuppression protocol in pediatric renal transplantation. Transplantation 72 (2001) 13
53. Sarwal M.M., Vidhun J.R., Alexander S.R., et al. Continued superior outcomes with modification and lengthened follow-up of a steroid-avoidance pilot with extended daclizumab induction in pediatric renal transplantation. Transplantation 76 (2003) 1331
54. Oberholzer J., John E., Lumpaopong A., et al. Early discontinuation of steroids is safe and effective in pediatric kidney transplant recipients. Pediatr Transplant 9 (2005) 456
55. Chavers B.M., Chang C., Gillingham K.J., et al. Successful pediatric kidney transplantation using a novel protocol of rapid discontinuation of prednisone. J Am Soc Nephrol (Abstracts Issue) 17 (2006) 672A
56. Haririan A., Sillix D.H., Morawski K., et al. Short-term experience with early steroid withdrawal in African-American renal transplant recipients. Am J Transplant 6 (2006) 2396
57. Boardman R.E., Alloway R.R., Alexander J.W., et al. African-American renal transplant recipients benefit from early corticosteroid withdrawal under modern immunosuppression. Am J Transplant 5 (2005) 356
58. Anil Kumar M.S., Moritz M.J., Saaed M.I., et al. Avoidance of chronic steroid therapy in AA kidney transplant recipients monitored by surveillance biopsy: 1-year results. Am J Transplant 5 (2005) 1976
59. Zeng X., El-Amm J.M., Doshi M.D., et al. Intermediate-term outcomes with early steroid withdrawal in African-American renal transplant recipients undergoing surveillance biopsy. Surgery 142 (2007) 538
60. Anil Kumar M.S., Khan S., Ranganna K., et al. Long-term outcome of early steroid withdrawal after kidney transplantation in African American recipients monitored by surveillance biopsy. Am J Transplant 8 (2008) 574
61. Ibrahim H., Rogers T., Casingal V., et al. Graft loss from recurrent glomerulonephritis is not increased with a rapid steroid discontinuation protocol. Transplantation 81 (2006) 214
62. Boardman R., Trofe J., Alloway R., et al. Early steroid withdrawal does not increase risk for recurrent focal segmental glomerulosclerosis. Transplant Proc 37 (2006) 817
63. Kwajha K., Asolati M., Harmon J.V., et al. Rapid discontinuation of prednisone in higher-risk kidney transplant recipients. Transplantation 78 (2004) 1397
64. Alloway R.R., Hanaway M.J., Trofe J., et al. A prospective, pilot study of early corticosteroid cessation in high-immunologic-risk patients: the Cincinnati experience. Transplant Proc 37 (2005) 802
65. Cantarovich D., Giral-Classe M., Hourmant M., et al. Low incidence of kidney rejection after simultaneous kidney-pancreas transplantation after antithymocyte globulin induction and in the absence of corticosteroids: results of a prospective pilot study in 28 consecutive cases. Transplantation 69 (2000) 1505
66. Kaufman D.B., Leventhal J.R., Koffron A.J., et al. A prospective study of rapid corticosteroid elimination in simultaneous pancreas-kidney transplantation: comparison of two maintenance immunosuppression protocols: tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus. Transplantation 73 (2002) 169
67. Gallon L.G., Winoto J., Chhabra D., et al. Long-term renal transplant function in recipient of simultaneous kidney and pancreas transplant maintained with two prednisone-free maintenance immunosuppressive combinations: tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus. Transplantation 83 (2007) 1324
68. Kaufman D.B., Leventhal J.R., Gallon L.G., et al. Alemtuzumab induction and prednisone-free maintenance immunotherapy in simultaneous pancreas-kidney transplantation comparison with rabbit antithymocyte globulin induction-long-term results. Am J Transplant 6 (2006) 331
69. Rajab A., Pelletier R.P., Ferguson R.M., et al. Steroid-free maintenance immunosuppression with Rapamune and low-dose Neoral in pancreas transplant recipients. Transplantation 84 (2007) 1131
70. Cantarovitch D., Karam G., Hourmant M., et al. Steroid avoidance versus steroid withdrawal after simultaneous pancreas-kidney transplantation. Am J Transplant 5 (2005) 1332
71. Anil Kumar M.S., Heifets M., Fyfe B., et al. Comparison of steroid avoidance in tacrolimus/mycophenolate mofetil and tacrolimus/sirolimus combination in kidney transplantation monitored by surveillance biopsy. Transplantation 80 (2005) 807
72. Kandaswamy R., Melancon J.K., Dunn T., et al. A prospective randomized trial of steroid-free maintenance regimens in kidney transplant recipients-an interim analysis. Am J Transplant 5 (2005) 1529
73. Gallon L., Perico N., Dimitrov B.D., et al. Long-term renal allograft function on a tacrolimus-based, pred-free maintenance immunosuppression comparing sirolimus versus MMF. Am J Transplant 6 (2006) 1617
74. Humar A., Gillingham K., Kandaswamy R., et al. Steroid avoidance regimens: a comparison of outcomes with maintenance steroids versus continued steroid avoidance in recipients having an acute rejection episode. Am J Transplant 7 (2007) 1948
75. Almawi W.Y., Melemedjian O.K., and Rieder M.J. An alternate mechanism of glucocorticoid anti-proliferative effect: promotion of a Th2 cytokine-secreting profile. Clin Transplant 13 (1999) 365
76. Cattaneo D., Perico N., Gaspari F., et al. Glucocorticoids interfere with mycophenolate mofetil bioavailability in kidney transplantation. Kidney Int 62 (2002) 1060
77. van Duijnhoven E.M., Boots J.M., Christiaans M.H., et al. Increase in tacrolimus trough levels after steroid withdrawal. Transpl Int 16 (2003) 721